Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy. - Wikidata - wikimedia - TriplyDB

Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.

Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.

http://www.wikidata.org/entity/Q37350365

about

Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy Evidence-based assessment of potential use of fingolimod in treatment of relapsing multiple sclerosis.Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model.Impaired dendritic cell function in a spontaneous autoimmune polyneuropathy.Sphingosine-1-phosphate signaling and its role in disease.Sphingosine 1-Phosphate Receptor Modulators and Drug Discovery.Animal models of autoimmune neuropathy.Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis.Autoimmune neuropathies: insights from animal models.Novel immunotherapeutic strategies in chronic inflammatory demyelinating polyneuropathy.Novel pathomechanisms in inflammatory neuropathies.IL-10 Paradoxically Promotes Autoimmune Neuropathy through S1PR1-Dependent CD4+ T Cell Migration.Regulatory T and B lymphocytes in a spontaneous autoimmune polyneuropathy.Fingolimod therapy is not effective in a mouse model of spontaneous autoimmune peripheral polyneuropathy.Fingolimod promotes blood-nerve barrier properties in vitro.Immune mechanisms in spontaneously occurring CIDP in NOD mice

P2860

Q27011473-EADD5185-DC30-4813-83F0-A737CA235DE3 Q34729032-D8DF3C3F-51AE-4B52-90B4-BA3CF80BCD30 Q34813347-6276C496-292A-4E5C-B5D4-65DFAD079533 Q35472467-274F3089-7694-43C2-AF82-5E1B3FBC16F2 Q35661485-6BC90BA1-E82D-49F4-A9E3-A00DC521404D Q37551932-0C130963-1C8B-4E12-8967-B1F039971011 Q37655234-6EF621DD-6AAC-4CBF-BC59-1B3E69FC633A Q37851885-57BFB118-2211-4FBD-AE1B-631A02CAD4FC Q38006760-E7E646C2-7F66-434B-895C-F776E141BBFE Q38711142-0621E46E-52E4-4A8E-B6AD-F28399FDB564 Q47126672-6AC250CC-1ACB-4C7A-A439-63B620AE5CD2 Q48172896-A16DADBA-3A57-443D-8C4D-00A66A840F3B Q50951132-8A4525A8-7C63-473A-ACBC-ECBB2189F7F7 Q52805929-977A1A7C-0F7F-499F-B379-61C8800F51FE Q55064386-FEE106D5-BF61-48A2-AB82-91FDBE8F75DC Q56898852-4BCE49BD-FF7F-4B48-9892-0CA95E448234

P2860

Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.

http://www.wikidata.org/entity/Q37350365

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 August 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.

@en

Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.

@nl

type

label

Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.

@en

Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.

@nl

prefLabel

Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.

@en

Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy.

@nl

P1433

Q37350365-CDF0378B-B0AE-4190-AA39-8BB10012A1C4

P1476

Q37350365-AE511E4E-93AE-4286-BC36-BDEC784C7AAB

P2093

Q37350365-40BFCC35-A569-4F3F-956C-A9D44699A2F0

Q37350365-548DE3B0-F67F-43D8-8E72-F02375CB334E

Q37350365-6A618BAF-C49F-4FBC-9BB3-39BD88F6ADF7

Q37350365-728BD37B-EF4C-4E26-8F5B-9742BFCFABCD

Q37350365-A34B6B8D-2F7A-4C4F-B3D8-0EB4E55E9A6B

Q37350365-CE7F42E2-7624-410C-BD85-50E9886FC951

P2860

Q37350365-062F5FBF-ACFE-4F1B-B948-ECCEF247A320

Q37350365-14A25983-645A-4811-A930-54A8896C0855

Q37350365-1F7A293C-20BE-4F80-B12B-B943458DBB21

Q37350365-225A1B48-3C78-4785-9768-069ECF004246

Q37350365-2D189E9E-C4C8-48BA-9F0D-886D0DD13845

Q37350365-302C9E52-64E8-4BAE-A2FA-0AF5BFF8F2F2

Q37350365-4151BD11-6605-4D99-B7FA-87AE7D05E545

Q37350365-46008E60-C520-43F0-B4D2-25A72203BA14

Q37350365-4AD8AB92-1F44-4DB5-9CD0-66C8B54FE989

Q37350365-60DC1903-D572-4102-94C0-7524CC8B3EB9

P304

Q37350365-A5D25CD5-7327-4117-9253-ADE34776D998

P31

Q37350365-E9F3AAC1-9744-4229-9E9D-8681C858881D

P356

Q37350365-47BC4C0B-E58E-44B9-B788-5E5F9E6FA285

P433

Q37350365-CEF1E7D4-D064-4146-8B49-34EB26437F2C

P478

Q37350365-D3D97FFD-D646-4B92-B16C-D19E9DC896C6

P50

Q37350365-502E6ED9-07AA-4668-87BC-7B34CEA466B2

P577

Q37350365-8149A3F1-783A-4498-9375-DFC10C7E3EBF

P5875

Q37350365-38ECABC1-1682-42BC-B76C-DC39A40FDCE1

P698

Q37350365-333F9CF3-6775-49BE-99E8-0CBD9E6BA420

P932

Q37350365-74BC6BCF-8E91-4EBB-A706-57EC1E52FFBC

P356

J.JNEUROIM.2009.07.006

P1433

Journal of Neuroimmunology

P1476

Fingolimod and related compounds in a spontaneous autoimmune polyneuropathy

@en

P2093

Betty Soliven

http://www.w3.org/2001/XMLSchema#string

Danuta Dukala

http://www.w3.org/2001/XMLSchema#string

Hye-Jung Kim

http://www.w3.org/2001/XMLSchema#string

Hyun Bae

http://www.w3.org/2001/XMLSchema#string

Rafael Kakazu

http://www.w3.org/2001/XMLSchema#string

Robert Wollmann

http://www.w3.org/2001/XMLSchema#string

P2860

Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists

Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1

Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.

Follicular shuttling of marginal zone B cells facilitates antigen transport.

Oral fingolimod (FTY720) for relapsing multiple sclerosis.

Lysophospholipid receptors are differentially expressed in rat terminal Schwann cells, as revealed by a single cell rt-PCR and in situ hybridization.

Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice.

Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization

Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology.

P304

93-100

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JNEUROIM.2009.07.006

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

214

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-08-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26710279

http://www.w3.org/2001/XMLSchema#string

P698

19647880

http://www.w3.org/2001/XMLSchema#string

P932

2745511

http://www.w3.org/2001/XMLSchema#string